Close
  • All
  • Centres
  • Courses
  • Events
  • News
  • People
  • Projects

Prof Pontiano Kaleebu

Professor of Immunovirology*

United Kingdom

Affiliations

MRC/UVRI and LSHTM Uganda Research Unit

Selected Publications

Uncovering the viral aetiology of undiagnosed acute febrile illness in Uganda using metagenomic sequencing.
Ashraf, S; Jerome, H; Bugembe, DL; Ssemwanga, D; Byaruhanga, T; Kayiwa, JT; Downing, R; Salazar-Gonzalez, JF; Salazar, MG; Shepherd, JG; Wilkie, C; Davis, C; Logan, N; Vattipally, SB; Wilkie, GS; Da Silva Filipe, A; Ssekagiri, A; Namuwulya, P; Bukenya, H; Kigozi, BK; McConnell, WW; Willett, BJ; Balinandi, S; Lutwama, J; KALEEBU, P; ... THOMSON, EC.
2025
Nature communications
The utility of integrating nanopore sequencing into routine HIV-1 drug resistance surveillance.
LULE, DB; Ssemwanga, D; KALEEBU, P; TULLY, DC;
2025
Microbial genomics
COVID-19 vaccination status and associated factors among patients presenting with COVID-19-like symptoms in Uganda.
KUSEMERERWA, S; Ankunda, V; Ongaria, TA; ABAASA, A; Kakande, A; Ssemwanga, D; Kimbugwe, G; Nayiga, B; Bosa, HK; Driwale, A; Woldemariam, YT; Kisakye, A; Humphreys, J; Worwui, AK; Cohuet, S; Mwenda, JM; ELLIOTT, AM; KALEEBU, P; RUZAGIRA, E;
2025
Vaccine
Effectiveness of COVID-19 vaccine against SARS-CoV-2 infection among symptomatic COVID-19 patients in Uganda.
ABAASA, AM; KUSEMERERWA, S; Ankunda, V; Ongaria, TA; Nayiga, B; Kakande, A; Ssemwanga, D; Kimbugwe, G; Bosa, HK; Woldemariam, YT; Kisakye, A; Humphreys, J; Worwui, AK; Cohuet, S; Mwenda, JM; ELLIOTT, AM; KALEEBU, P; RUZAGIRA, E;
2025
Vaccine
Low-Dose Yellow Fever Vaccine in Adults in Africa.
Kimathi, D; Juan-Giner, A; Bob, NS; Orindi, B; Namulwana, ML; Diatta, A; Cheruiyot, S; Fall, G; Dia, M; Hamaluba, MM; Nyehangane, D; Karanja, HK; Gitonga, JN; Mugo, D; Omuoyo, DO; Hussein, M; Oloo, E; Kamau, N; Wafula, J; Bendera, J; Silvester, N; Mwavita, J; Joshua, M; Mwendwa, J; Agababyona, C; ... NIFTY Investigators,
2025
The New England journal of medicine
Long-Term Immune Consequences of Initial SARS-CoV-2 A.23.1 Exposure: A Longitudinal Study of Antibody Responses and Cross-Neutralization in a Ugandan Cohort.
Oluka, GK; Sembera, J; Katende, JS; Ankunda, V; Kato, L; Kurshan, A; Graham, C; Seow, J; Doores, KJ; Malim, MH; Fox, JM; KALEEBU, P; SERWANGA, J;
2025
Vaccines
Identification of Anthrax as the Cause of a Cluster of Unexplained Deaths, Uganda, 2023: The Role of Metagenomic Next-Generation Sequencing and Postmortem Specimens.
BBOSA, N; Ssemwanga, D; Weiss, SL; Kalungi, S; Mawanda, A; Ssentudde, R; Ssekyeru, E; Ssekagiri, A; Kiiza, R; Rwankindo, C; Buule, J; Namagembe, HS; Nabirye, S; Nassolo, JP; Downing, R; Lutwama, J; Lutalo, T; Kyobe Bosa, H; Berg, MG; Rodgers, MA; Averhoff, F; Cloherty, GA; KALEEBU, P;
2025
The American journal of tropical medicine and hygiene
Ebola disease: bridging scientific discoveries and clinical application.
Rojek, A; Fieggen, J; Apiyo, P; Caluwaerts, S; Fowler, RA; KALEEBU, P; Kojan, R; Lado, M; Lambe, T; Dunning, J; Horby, P;
2024
The Lancet. Infectious diseases
Case Reports of Human Monkeypox Virus Infections, Uganda, 2024.
BBOSA, N; Nabirye, SE; Namagembe, HS; Kiiza, R; Ssekagiri, A; Munyagwa, M; Bwambale, A; Bagonza, S; Bosa, HK; Downing, R; Lutwama, J; KALEEBU, P; Ssemwanga, D;
2024
Emerging infectious diseases
See more information